BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
See today's BioWorld
Home
» Other news to note for Sept. 22, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 22, 2021
Sep. 22, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Addex, Azurrx, Blue Water, CG, Charcot-Marie-Tooth Association, Cinfina, Comet, Cyclerion, Eli Lilly, First Wave, Forge, Immunic, J&J, Janssen, Landos, Merck, Mirum, Model, Mosaic, Nektar, Novartis, Oryzon, Oxford University Innovation, Persephone, Pfizer, Pharmacyte, Puretech, Q Biomed, Renovion, Roche, Seneca, Takeda, Therapeutic Solutions, Vectivbio, Vesselon.
BioWorld
Briefs
Other news to note
Coronavirus